LIPODYSTROPHY
Clinical trials for LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Special access opens for rare metabolic and obesity disorders
Disease control AVAILABLEThis program provides special access to an investigational drug called REGN4461 for patients with rare diseases where the body's leptin signaling is deficient. It is for conditions like lipodystrophy (abnormal fat distribution) and monogenic obesity (a genetic form of obesity). A…
Matched conditions: LIPODYSTROPHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists trace fat in rare body disorder
Knowledge-focused Recruiting nowThis study aims to understand how fat tissue works in people with a rare condition called familial partial lipodystrophy (FPLD), where the body stores fat abnormally. Researchers will compare small fat samples from 5 people with FPLD to samples from 5 healthy volunteers. The main…
Matched conditions: LIPODYSTROPHY
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Researchers ask: is a Fat-Regulating drug safe for pregnancy?
Knowledge-focused Recruiting nowThis study aims to gather information about pregnancy in women with lipodystrophy, a rare condition involving a lack of fat tissue. Researchers want to understand if taking a hormone-replacement drug called metreleptin during pregnancy affects the mother's health or the health of…
Matched conditions: LIPODYSTROPHY
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC